A cheap gout medication, colchicine, shows significant promise in preventing heart attacks and strokes for individuals with existing heart disease. A new Cochrane review highlights its ability to ...

Gout is the most common form of inflammatory arthritis, with a worldwide prevalence of approximately 4%. The accumulation of ...

Colchicine is an anti-inflammatory drug prescribed to treat gout. Prices vary depending on insurance but range between $5 to ...

A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...

A widely available drug used for gout may help prevent heart attacks and stroke in people with cardiovascular disease. | Drug ...

WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and ...

October 2, 2012 — New gout guidelines from the American College of Rheumatology are meant to improve gout management by providing clinicians with clear, readily implemented guidance on urate-lowering ...

LONDON, June 8 (Reuters) - A drug used for more than 40 years to treat gout could also offer a cheap alternative to more modern heart drugs from Roche and Servier for patients with chronic chest pain, ...

New findings that a common treatment for gout also cuts heart attacks adds weight to the idea that the 'plumbing' theory of ...

For gout pain that does not respond to conventional therapies, patients’ only remaining option is a drug from Amgen. But this biologic medicine introduces the same problem facing every therapeutic ...

East Brunswick’s Savient Pharmaceuticals Inc. is starting the new year with a major boost. Savient’s chronic gout drug, Krystexxa, now has its own permanent billing code from the Centers for Medicare ...